Gottlieb to leave FDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb will return to the American Enterprise Institute following his resignation from the agency, effective Jan. 16. Gottlieb will join former FDA/CMS chief Mark McClellan, who joined an AEI/Brookings Institution collaborative center in November after departing CMS in October. Gottlieb is the second senior advisor to von Eschenbach to announce a departure for January: FDA Chief of Staff Patrick Ronan recently said he would resign his post effective Jan. 5...